LLY logo

Eli Lilly and Company (LLY) Cash and cash equivalents

annual cash & cash equivalents:

$3.27B+$449.80M(+15.96%)
December 31, 2024

Summary

  • As of today (May 29, 2025), LLY annual cash & cash equivalents is $3.27 billion, with the most recent change of +$449.80 million (+15.96%) on December 31, 2024.
  • During the last 3 years, LLY annual cash & cash equivalents has fallen by -$550.10 million (-14.41%).
  • LLY annual cash & cash equivalents is now -55.35% below its all-time high of $7.32 billion, reached on December 31, 2018.

Performance

LLY Cash and cash equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLLYbalance sheet metrics

quarterly cash & cash equivalents:

$3.09B-$175.10M(-5.36%)
March 31, 2025

Summary

  • As of today (May 29, 2025), LLY quarterly cash & cash equivalents is $3.09 billion, with the most recent change of -$175.10 million (-5.36%) on March 31, 2025.
  • Over the past year, LLY quarterly cash & cash equivalents has increased by +$633.10 million (+25.73%).
  • LLY quarterly cash & cash equivalents is now -65.48% below its all-time high of $8.96 billion, reached on September 30, 2018.

Performance

LLY quarterly cash & cash equivalents Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherLLYbalance sheet metrics

Cash and cash equivalents Formula

Cash & Cash Equivalents = Cash + Short-Term Investments

LLY Cash and cash equivalents Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+16.0%+25.7%
3 y3 years-14.4%+25.8%
5 y5 years+39.8%+82.1%

LLY Cash and cash equivalents Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-14.4%+58.1%-12.8%+49.6%
5 y5-year-14.4%+58.1%-19.0%+82.1%
alltimeall time-55.4%+911.9%-65.5%+1242.6%

LLY Cash and cash equivalents History

DateAnnualQuarterly
Mar 2025
-
$3.09B(-5.4%)
Dec 2024
$3.27B(+16.0%)
$3.27B(-3.0%)
Sep 2024
-
$3.37B(+4.5%)
Jun 2024
-
$3.22B(+31.0%)
Mar 2024
-
$2.46B(-12.7%)
Dec 2023
$2.82B(+36.4%)
$2.82B(+18.4%)
Sep 2023
-
$2.38B(-11.6%)
Jun 2023
-
$2.69B(-24.0%)
Mar 2023
-
$3.55B(+71.5%)
Dec 2022
$2.07B(-45.9%)
$2.07B(-21.0%)
Sep 2022
-
$2.62B(-0.2%)
Jun 2022
-
$2.62B(+6.7%)
Mar 2022
-
$2.46B(-35.6%)
Dec 2021
$3.82B(+4.4%)
$3.82B(+0.8%)
Sep 2021
-
$3.79B(+17.6%)
Jun 2021
-
$3.22B(+7.2%)
Mar 2021
-
$3.00B(-17.9%)
Dec 2020
$3.66B(+56.5%)
$3.66B(+1.7%)
Sep 2020
-
$3.60B(+52.0%)
Jun 2020
-
$2.37B(+39.2%)
Mar 2020
-
$1.70B(-27.3%)
Dec 2019
$2.34B(-68.1%)
$2.34B(+49.5%)
Sep 2019
-
$1.56B(-31.7%)
Jun 2019
-
$2.29B(+12.5%)
Mar 2019
-
$2.04B(-72.2%)
Dec 2018
$7.32B(+12.0%)
$7.32B(-18.3%)
Sep 2018
-
$8.96B(+31.4%)
Jun 2018
-
$6.82B(+121.0%)
Mar 2018
-
$3.08B(-52.8%)
Dec 2017
$6.54B(+42.6%)
$6.54B(+75.5%)
Sep 2017
-
$3.72B(+21.3%)
Jun 2017
-
$3.07B(+17.3%)
Mar 2017
-
$2.62B(-42.9%)
Dec 2016
$4.58B(+25.0%)
$4.58B(+31.3%)
Sep 2016
-
$3.49B(+7.8%)
Jun 2016
-
$3.24B(+40.3%)
Mar 2016
-
$2.31B(-37.1%)
Dec 2015
$3.67B(-5.3%)
$3.67B(+13.2%)
Sep 2015
-
$3.24B(-2.3%)
Jun 2015
-
$3.32B(+8.2%)
Mar 2015
-
$3.06B(-20.8%)
Dec 2014
$3.87B(+1.1%)
$3.87B(+22.3%)
Sep 2014
-
$3.17B(-15.9%)
Jun 2014
-
$3.77B(-3.1%)
Mar 2014
-
$3.89B(+1.5%)
Dec 2013
$3.83B(-4.7%)
$3.83B(-12.3%)
Sep 2013
-
$4.37B(+15.4%)
Jun 2013
-
$3.79B(-3.8%)
Mar 2013
-
$3.94B(-2.0%)
Dec 2012
$4.02B(-32.1%)
$4.02B(-24.4%)
Sep 2012
-
$5.32B(+22.4%)
Jun 2012
-
$4.35B(+5.4%)
Mar 2012
-
$4.12B(-30.4%)
Dec 2011
$5.92B(-1.2%)
$5.92B(-10.2%)
Sep 2011
-
$6.60B(+7.9%)
Jun 2011
-
$6.11B(-6.0%)
Mar 2011
-
$6.51B(+8.6%)
Dec 2010
$5.99B(+34.3%)
$5.99B(+16.1%)
Jun 2010
-
$5.16B(+9.3%)
Mar 2010
-
$4.73B(+5.9%)
Dec 2009
$4.46B(-18.8%)
$4.46B(+16.0%)
Sep 2009
-
$3.85B(+15.8%)
Jun 2009
-
$3.32B(+0.3%)
Mar 2009
-
$3.31B(-39.7%)
Dec 2008
$5.50B(+70.7%)
$5.50B(+26.3%)
Sep 2008
-
$4.35B(+51.8%)
Jun 2008
-
$2.87B(-8.8%)
Mar 2008
-
$3.15B(-2.3%)
Dec 2007
$3.22B(+3.6%)
$3.22B(+29.1%)
Sep 2007
-
$2.50B(+12.4%)
Jun 2007
-
$2.22B(-10.9%)
Mar 2007
-
$2.49B(-19.9%)
Dec 2006
$3.11B
$3.11B(+43.3%)
Sep 2006
-
$2.17B(-18.7%)
DateAnnualQuarterly
Jun 2006
-
$2.67B(+8.6%)
Mar 2006
-
$2.46B(-18.2%)
Dec 2005
$3.01B(-44.0%)
$3.01B(-39.5%)
Sep 2005
-
$4.97B(+7.1%)
Jun 2005
-
$4.64B(-17.2%)
Mar 2005
-
$5.61B(+4.5%)
Dec 2004
$5.37B(+94.7%)
$5.37B(+108.2%)
Sep 2004
-
$2.58B(+7.5%)
Jun 2004
-
$2.40B(-0.6%)
Mar 2004
-
$2.41B(-12.5%)
Dec 2003
$2.76B(+41.6%)
$2.76B(-5.5%)
Sep 2003
-
$2.92B(+43.1%)
Jun 2003
-
$2.04B(-7.6%)
Mar 2003
-
$2.20B(+13.3%)
Dec 2002
$1.95B(-28.0%)
$1.95B(-30.2%)
Sep 2002
-
$2.79B(-8.7%)
Jun 2002
-
$3.05B(+5.9%)
Mar 2002
-
$2.88B(+6.6%)
Dec 2001
$2.70B(-34.3%)
$2.70B(+2.1%)
Sep 2001
-
$2.65B(-11.0%)
Jun 2001
-
$2.97B(-8.0%)
Mar 2001
-
$3.23B(-21.5%)
Dec 2000
$4.11B(+11.2%)
$4.11B(+32.0%)
Sep 2000
-
$3.12B(-7.5%)
Jun 2000
-
$3.37B(-11.3%)
Mar 2000
-
$3.80B(+2.6%)
Dec 1999
$3.70B(+147.4%)
$3.70B(+12.4%)
Sep 1999
-
$3.29B(+62.0%)
Jun 1999
-
$2.03B(-15.5%)
Mar 1999
-
$2.40B(+60.8%)
Dec 1998
$1.50B(-23.2%)
$1.50B(-3.1%)
Sep 1998
-
$1.54B(+17.4%)
Jun 1998
-
$1.32B(+4.0%)
Mar 1998
-
$1.26B(-35.1%)
Dec 1997
$1.95B(+139.3%)
$1.95B(+29.5%)
Sep 1997
-
$1.50B(-18.8%)
Jun 1997
-
$1.85B(+77.8%)
Mar 1997
-
$1.04B(+28.1%)
Dec 1996
$813.70M(-18.6%)
$813.70M(+10.2%)
Sep 1996
-
$738.10M(-34.4%)
Jun 1996
-
$1.13B(+25.2%)
Mar 1996
-
$898.40M(-10.1%)
Dec 1995
$999.50M(+86.2%)
$999.50M(+2.4%)
Sep 1995
-
$976.20M(-1.4%)
Jun 1995
-
$989.70M(+1.1%)
Mar 1995
-
$978.80M(+82.3%)
Dec 1994
$536.90M(-0.5%)
$536.90M(-46.3%)
Sep 1994
-
$999.60M(+41.4%)
Jun 1994
-
$706.80M(+16.8%)
Mar 1994
-
$604.90M(+12.1%)
Dec 1993
$539.60M(+24.8%)
$539.60M(-15.2%)
Sep 1993
-
$636.10M(+42.1%)
Jun 1993
-
$447.70M(-24.7%)
Mar 1993
-
$594.60M(+37.5%)
Dec 1992
$432.40M(-9.8%)
$432.40M(+21.7%)
Sep 1992
-
$355.20M(-16.5%)
Jun 1992
-
$425.40M(+21.1%)
Mar 1992
-
$351.30M(-26.7%)
Dec 1991
$479.20M(+36.8%)
$479.20M(+63.3%)
Sep 1991
-
$293.50M(+27.4%)
Jun 1991
-
$230.40M(-23.9%)
Mar 1991
-
$302.80M(-13.5%)
Dec 1990
$350.20M(+8.4%)
$350.20M(-29.1%)
Sep 1990
-
$494.00M(+7.6%)
Jun 1990
-
$459.10M(+9.5%)
Mar 1990
-
$419.30M(+29.8%)
Dec 1989
$323.00M(-57.6%)
$323.00M(-45.0%)
Sep 1989
-
$587.40M(+2.6%)
Jun 1989
-
$572.40M(-24.8%)
Dec 1988
$761.50M(-26.1%)
$761.50M(-26.1%)
Dec 1987
$1.03B(+112.1%)
$1.03B(+112.1%)
Dec 1986
$486.00M(+19.7%)
$486.00M(+19.7%)
Dec 1985
$406.10M(-8.8%)
$406.10M(-8.8%)
Dec 1984
$445.30M
$445.30M

FAQ

  • What is Eli Lilly and Company annual cash & cash equivalents?
  • What is the all time high annual cash & cash equivalents for Eli Lilly and Company?
  • What is Eli Lilly and Company annual cash & cash equivalents year-on-year change?
  • What is Eli Lilly and Company quarterly cash & cash equivalents?
  • What is the all time high quarterly cash & cash equivalents for Eli Lilly and Company?
  • What is Eli Lilly and Company quarterly cash & cash equivalents year-on-year change?

What is Eli Lilly and Company annual cash & cash equivalents?

The current annual cash & cash equivalents of LLY is $3.27B

What is the all time high annual cash & cash equivalents for Eli Lilly and Company?

Eli Lilly and Company all-time high annual cash & cash equivalents is $7.32B

What is Eli Lilly and Company annual cash & cash equivalents year-on-year change?

Over the past year, LLY annual cash & cash equivalents has changed by +$449.80M (+15.96%)

What is Eli Lilly and Company quarterly cash & cash equivalents?

The current quarterly cash & cash equivalents of LLY is $3.09B

What is the all time high quarterly cash & cash equivalents for Eli Lilly and Company?

Eli Lilly and Company all-time high quarterly cash & cash equivalents is $8.96B

What is Eli Lilly and Company quarterly cash & cash equivalents year-on-year change?

Over the past year, LLY quarterly cash & cash equivalents has changed by +$633.10M (+25.73%)
On this page